Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium.

Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium. Abstract Text:

Kenichiroh Mukawa,Shigehiko Fujii,Keiichi Tominaga,Naoto Yoshitake,Akihito Abe,Tokuyuki Kono,Akira Sekikawa,Hirokazu Fukui,Kazuhito Ichikawa,Shigeki Tomita,Johji Imura,Yuko Ono,Motoo Shinoda,Hideyuki Hiraishi,Takahiro Fujimori,Kenichiroh Mukawa,Shigehiko Fujii,Keiichi Tominaga,Naoto Yoshitake,Akihito Abe,Tokuyuki Kono,Akira Sekikawa,Hirokazu Fukui,Kazuhito Ichikawa,Shigeki Tomita,Johji Imura,Yuko Ono,Motoo Shinoda,Hideyuki Hiraishi,Takahiro Fujimori,

Non-steroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 (COX-2) inhibitors are representative agents for the chemoprevention of sporadic colorectal neoplasia. However, few reports have described the chemopreventive effects of such agents on colitis-associated tumorigenesis. To clarify whether treatment with the COX-2 inhibitor may reduce the risk of colitis-associated neoplasia, we investigated the effect of one such agent, etodolac, on tumorigenesis in the colitis-associated neoplasia model using p53-deficient mice treated with dextran sulfate sodium (DSS). The p53-/- mice were divided into four groups: i) treatment with DSS + etodolac, then after two cycles of DSS, the mice were given distilled water for 84 days. In addition, etodolac was administered three times a week at a dose of 10 mg/kg body weight throughout the experiment. ii) Treatment with two cycles of DSS only, followed by distilled water for 84 days. iii) Treatment with etodolac alone. iv) Distilled water alone was administered to the control group. The incidence of mice with neoplasia was 82.4% in the DSS + etodolac group and 100% in the DSS-alone group. No neoplasia was observed in the etodolac-alone and control groups. The mean (+/- SEM) number of total neoplasias per mouse was 1.29+/-0.2 in the DSS + etodolac group and 3.0+/-0.52 in the DSS-alone group, the inter-group difference being significant (p<0.01). There was no significant difference in the inflammation score between these two groups. These results showed that treatment with etodolac significantly reduced the occurrence of neoplasia, suggesting that this COX-2 inhibitor has chemopreventive activity against colitis-associated tumorigenesis.

Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium. Publishing Authors By Initials

K Mukawa,S Fujii,K Tominaga,N Yoshitake,A Abe,T Kono,A Sekikawa,H Fukui,K Ichikawa,S Tomita,J Imura,Y Ono,M Shinoda,H Hiraishi,T Fujimori,K Mukawa,S Fujii,K Tominaga,N Yoshitake,A Abe,T Kono,A Sekikawa,H Fukui,K Ichikawa,S Tomita,J Imura,Y Ono,M Shinoda,H Hiraishi,T Fujimori,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Oncology reports

VOLUME: 19

Page Numbers: 393-9

Journal Abbreviation: Oncol. Rep.

ISSN: 1021-335X

DAY: 18

MONTH: Feb

YEAR: 2008

Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9422756

Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium.

AFFILIATION: Department of Surgical and Molecular Pathology, Dokkyo Medical University School of Medicine, Tochigi 321-0293, Japan.

Country: Greece

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Oncol Rep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium Related Publications

• Depth of tumor invasion in locally advanced rectal cancer correlates with patients' prognosis: The usefulness of elastic stain for its measurement.
• Development of simple sequence repeat (SSR) markers and construction of an SSR-based linkage map in Italian ryegrass (Lolium multiflorum Lam.).
• EFFECTS OF BRAIN-STEM STIMULATION UPON HIPPOCAMPAL ELECTRICAL ACTIVITY, SOMATOMOTOR REFLEXES AND AUTONOMIC FUNCTIONS.
• EXTL3 promoter methylation down-regulates EXTL3 and heparan sulphate expression in mucinous colorectal cancers.
• Electric birefringence of ionized polypeptides in solution and the effect of high electric fields on the helix-coil transition.
• Exogeneous Cytosine Deaminase Gene Expression in Bifidobacterium breve I-53-8w for Tumor-Targeting Enzyme/Prodrug Therapy.
• Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer.
• FAST ACTIVITIES AND DC POTENTIAL CHANGES OF THE CEREBRAL CORTEX DURING EEG AROUSAL RESPONSE.
• Hemorrhagic enteritis due to poisonous mushroom.
• Hepatic changes in adenine nucleotide levels and adenosine 3'-monophosphate forming enzyme in streptozotocin-induced diabetic mice.
• Human papillomavirus infection is involved in the development of colonic squamous cell dysplasia in ulcerative colitis-associated carcinogenesis.
• Impact of age and procedure on resource use for patients with ischemic heart disease.
• Inhibitory effects of the cyclooxygenase-2 inhibitor, etodolac, on colitis-associated tumorigenesis in p53-deficient mice treated with dextran sulfate sodium.
• Melatonin Its intracellular and genomic actions.
• Metastasis to the appendix from gastric cancer detected incidentally on colonoscopy.
• Molecular Analysis of Hypoxanthine Guanine Phosphoribosyltransferase (HPRT) Deficiencies: Novel Mutations and the Spectrum of Japanese Mutations.
• Polypectomy as a diagnostic tool for ileocecal lymphoma.
• Postinfectious cough and gastroesophageal reflux-induced cough.
• Psychophysiological study on the depth of sleep in normal human subjects.
• Purine contents of soybean-derived foods and selected Japanese vegetables and mushrooms.
• REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells.
• The CD155/poliovirus receptor enhances the proliferation of ras-mutated cells.
• Total synthesis of RK-397.
• [Anaerobic bacteria as a gene delivery system for breast cancer therapy]
• [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia]
• [Hemorrhage and hemostasis in tumors: nasal and par paranasal cavities.]
• [Nursing of a patient in the acute stage of a spinal cord injury]